The rpoB gene encodes the beta subunit of the DNA-dependent RNA polymerase of bacteria. Mutations in defined areas result in resistance to rifampin. Mycobacterium smegmatis is naturally resistant to rifampin, but analysis of the rpoB gene revealed no identifiable rifampin resistance mutations. Another mechanism of resistance may be present.
The rpoB gene of bacteria encodes the beta subunit of the DNA-dependent RNA polymerase (13) . It is an important target for antimycobacterial drugs, such as rifampin, which exerts its effect by binding to the RNA polymerase and preventing transcription. Rifampin resistance in Escherichia coli has been shown to result from point mutations in four welldefined regions, or clusters, of rpoB (6, 14) . Recently, strains of Mycobacterium tuberculosis resistant to rifampin have been shown to possess mutations in the largest of these rifampin resistance clusters. The types of mutations include single nucleotide changes and in-frame deletions and insertions. The rpoB gene of M. tuberculosis has recently been cloned and sequenced (11, 17) .
Mycobacterium smegmatis is a species that rarely causes disease in humans, but it is an important tool for the genetic manipulation of mycobacterial DNA (6) . For instance, certain strains are efficient hosts for the electroporation of DNA (16) . Also, the low pathogenicity of this species, its ability to grow rapidly over days instead of weeks, and its 90% genetic homology to M. tuberculosis are reasons why M. smegmatis is an important model for genetic studies of mycobacterial species. Here we report the cloning and sequencing of the rpoB gene of M. smegmatis and identify characteristics that may shed additional light on the genetics of resistance to rifampin.
M. smegmatis (ATCC 14468) was grown in Middlebrook medium for 3 days at 37ЊC with shaking. The MIC of rifampin was determined to be 4 g/ml by the E-Test (AB Biodisk, Solna, Sweden). The DNA was isolated by first disrupting cells with the use of glass beads in a Bead-Beater apparatus (Biospec Products, Bartlesville, Okla.) and phenol-chloroform extraction. DNA was amplified by PCR with the primers described by Telenti et al. (17) . The resultant 432-bp product was sequenced by using the PCR primers, the fmol cycle sequencing kit (Promega, Madison, Wis.), and a 6% polyacrylamide gel (Sequagel-6; National Diagnostics, Atlanta, Ga.). We amplified sequences upstream and downstream from this core fragment by the method of rapid amplification of genomic DNA ends (12) . By repeating the procedure in both upstream and downstream directions, we sequenced overlapping fragments totalling 4 kbp of M. smegmatis DNA that spanned the entire rpoB gene. All fragments were shown to belong to the rpoB gene by homology to the rpoB gene of E. coli (GenBank accession no. V00340).
We cloned the entire rpoB gene of M. smegmatis using the following strategy. We used PCR to prepare a 2-kbp, [
32 P] dCTP-labelled probe (Prime-It II kit; Stratagene, La Jolla, Calif.). The probe was used to identify a 6-kbp fragment of SphI-cut M. smegmatis DNA by Southern hybridization (2) . A mini-library was prepared by ligation of DNA from the 6-kbp band to a SphI-cut vector (pGem3Zf; Promega) and transformation into E. coli DH5␣. Bacterial colonies of the resultant mini-library were screened directly by PCR with the PCR primers of Telenti et al. (17) . One colony of 96 screened was positive. Plasmid DNA was recovered from a culture of this clone by using the Qiagen plasmid maxi kit (Qiagen, Chatsworth, Calif.). The clone was partially sequenced, including the start and stop codons, with the Sequenase kit (US Biochemical Corp., Cleveland, Ohio). Areas of compression were sequenced again by cycle sequencing. Both strands were sequenced at least twice. All sequence data were analyzed with the Wisconsin Package software (Genetics Computer Group, Madison, Wis.).
Of the total of 3,752 bases sequenced, there was 85% homology with the rpoB gene of M. tuberculosis and 82.6% homology with that of Mycobacterium leprae. The partial sequence of the rpoB clone contained an open reading frame of 3,507 bases. Like the M. tuberculosis counterpart, the M. smegmatis rpoB gene uses GTG as the probable start codon. The 1,169-amino-acid protein encoded by the rpoB gene was 90.1 and 88.8% homologous to the beta subunits of the RNA polymerases from M. tuberculosis and M. leprae, respectively (Fig.  1) .
By analogy to the E. coli rpoB gene, four regions potentially associated with rifampin resistance were identified. The valine at position 167 corresponds to Val-146 of E. coli, where mutations have been rarely identified with rifampin resistance (10) . Three clusters contain the majority of resistance mutations identified in E. coli. The 23 amino acids at positions 427 to 449 correspond to cluster I, those at positions 479 to 490 correspond to cluster II, and the single amino acid Arg-604 corresponds to cluster III (a misnomer, since there is but one location) (7, 15) . Mutations in clinical Mycobacterium isolates resistant to rifampin have been localized only to cluster I (4, 7, 17) . A small percentage of rifampin-resistant M. tuberculosis strains have no identifiable mutations in rpoB (7, 17) .
In the M. smegmatis rpoB gene there were no mutations corresponding to any of the known rifampin resistance genotypes, despite the fact that the MIC for this isolate was 4 g/ml, well above the level considered to indicate resistance. Guerrero et al. obtained similar results upon sequencing cluster I (Rif locus) of Mycobacterium avium and Mycobacterium intracellulare (3) . In that study, all strains, regardless of rifampin susceptibility, had amino acid identity to the sequence found in rifampin-susceptible M. tuberculosis. Thus, there must be factors other than the mutations in the identified rpoB clusters that cause the rifampin resistance of M. smegmatis and perhaps those isolates of M. tuberculosis that lack cluster I mutations. One possibility is that there are other areas of rpoB in which mutations may confer resistance. Alternatively, mutations in other subunits of the polymerase could contribute to rifampin resistance, perhaps by altering the conformation of the rifampin binding region of the beta subunit. In this regard, Levin and Hatfull raised a rifampin-resistant mutant of M. smegmatis (MIC Ͼ 50 g/ml) (9) . They demonstrated in an in vitro transcription system that purified RNA polymerase from the mutant was less sensitive to rifampin than polymerase from the parent strain. Neither the genetic mechanism of the decreased sensitivity nor the subunit localization of the presumed mutation was defined. Another report identified a non-rpoB mutation causing rifampin resistance in E. coli (8) . These results, however, do not exclude the intriguing possibility that another mechanism of drug resistance is present, such as diminished antibiotic entry into the bacteria, efflux, or enzymatic degradation or modification of rifampin. Recent reports hint that the latter mechanism may be present in Nocardia spp. (1, 18) .
Nucleotide sequence accession number. The sequence of the M. smegmatis rpoB gene is in the GenBank database under accession no. U24494. 
